ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer. | Int J Gynecol Cancer;22(1): 175, 2012 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer.

van der Zee, Ate G J; Colombo, Nicoletta; Gitsch, Gerald; Reed, Nicolas; Amant, Frederic; Cibula, David; Kesic, Vesna I; Kimmig, Rainer; Lopes, Alberto D B; Markowska, Janina; Marth, Christian; Radolakis, Alexander; Salvesen, Helga; Vaitkiene, Daiva; Verheijen, René H M; Zola, Paolo.

Int J Gynecol Cancer ; 22(1): 175, 2012 Jan.

Article in En | MEDLINE | ID: mdl-22193647

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplasms, Glandular and Epithelial / CA-125 Antigen / Neoplasm Recurrence, Local Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2012 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplasms, Glandular and Epithelial / CA-125 Antigen / Neoplasm Recurrence, Local Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2012 Document type: Article Country of publication: